Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-17

FDA Approved: TECHNETIUM TC 99M SESTAMIBI — Supplemental Application (Curium US LLC)

View source ↗

Summary

FDA approved a supplemental application for Technetium Tc-99m Sestamibi, updating its labeling and approved use in diagnostic myocardial perfusion imaging under…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Technetium Tc-99m Sestamibi (Technetium Tc-99m Sestamibi)

Snippet

SUPPL AP for TECHNETIUM TC 99M SESTAMIBI (TECHNETIUM TC 99M SESTAMIBI)